Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orthana, officially known as Orthana Bioproducts A/S, is a Danish life science company specializing in the extraction and purification of high-quality biomolecules from animal-derived raw materials. Founded in 1945 and acquired by Bioiberica in 1999, the company is a global leader in the production of mucins, peptones, and glandular extracts. These products serve as essential ingredients for the pharmaceutical, diagnostic, and nutraceutical industries, particularly in treatments for gastrointestinal and respiratory health. Orthana operates a state-of-the-art, GMP-certified manufacturing facility in Kastrup, Denmark, ensuring rigorous safety and quality standards. The company's expertise in complex biological extraction makes it a critical supplier for cell culture media and specialized medical applications worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orthana.